&nbsp;

Intent: Palliative

Funding:

New Drug Funding Program

Sacituzumab Govitecan - Unresectable Locally Advanced or Metastatic Triple Negative Breast Cancer

New Drug Funding Program

Sacituzumab Govitecan - HR-positive HER2-negative Unresectable Locally Advanced or Metastatic Breast Cancer

Drugs Used:

sacituzumab govitecan

... Show more tags

Quick Link(s):

Regimen Monograph

Jul 2025

Regimen

SMILE(PEG)

Cancer Type:

Hematologic,

Lymphoma - T-cell

Intent: Curative

Funding:

New Drug Funding Program

Pegaspargase - Extranodal Natural Killer/T-cell Lymphoma

Drugs Used:

mesna,

Quick Link(s):

Regimen Monograph

Sep 2023

Regimen

SOTO

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Drugs Used:

sotorasib (Unfunded)

... Show more tags

Quick Link(s):

Regimen Monograph

Feb 2022

Regimen

VEMU+RITU

Cancer Type:

Hematologic,

Leukemia - Hairy Cell

Intent: Palliative

Drugs Used:

vemURAFenib (Unfunded),

riTUXimab (Unfunded)

... Show more tags

Quick Link(s):

Regimen Monograph

Mar 2022

Document

Screening-and-Management-of-Hep-B.pdf

Aug 2022

Document

Screening-and-Management-of-Hep-B_FR.pdf

Aug 2022

Document

SCO2022donnees-FR

Aug 2022

Guidelines and Advice

Systemic Therapy for Metastatic Urothelial Cancer: An Endorsement of a Portion of the European Association of Urology Guideline on Muscle-Invasive and Metastatic Bladder Cancer

Status: In-Review
ID: GL END 3-24

Aug 2022

Document

SelectedCancerRiskAmongFirefighters.png

Nov 2022

Document